Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
DUOMED BELGIUM from Mechelen, company number BE0416834437, closed financial year 2025 with a result of € -10.4 million after tax. For that financial year DUOMED BELGIUM recorded revenue of € 113.3 million and equity of € 79.7 million. Compared with financial year 2024, the result moved from € 34.1 million to € -10.4 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 79.7 million
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -10.4 million
▼ still € 34.1 million profit in 2024
Profit after tax over the fiscal year.
€ 79,690
▼ 92% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 73 million.
People and assets in 2025
214.2
▼ 3.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 24.3 million
▲ 7% vs 2024
€ 113,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 42,454
▼ 72% vs 2024
Of which on lease € 422.
Debts at end 2025
€ 200.6 million
▲ 24% vs 2024
Loans from banks and other lenders, long and short.
€ 18.4 million
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 85 days on average.
€ 7.7 million
▼ 6% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 65,056,563 | € 109,827,581 | € 106,986,002 | € 113,330,910 | ▲ 6% |
| Profit after taxes | € 1,654,706 | € 2,951,929 | € 34,099,118 | € -10,369,740 | ▼ € 44.5 million |
| Equity | € 49,770,550 | € 56,000,023 | € 90,093,691 | € 79,667,283 | ▼ 12% |
| Total debts | € 64,448,900 | € 68,077,010 | € 191,301,271 | € 238,954,028 | ▲ 25% |
| Cash | € 14,720,480 | € 16,714,562 | € 1,017,733 | € 79,690 | ▼ 92% |
| Land & buildings | € 153,430 | € 94,399 | € 89,006 | € 45,219 | ▼ 49% |
| Retained profit | € 47,046,258 | € 49,350,169 | € 83,449,287 | € 73,022,879 | ▼ 12% |
| Bank debt | € 35,996,678 | € 35,156,677 | € 161,927,968 | € 200,638,711 | ▲ 24% |
| Balance sheet total | € 114,376,673 | € 124,710,686 | € 281,450,962 | € 318,645,104 | ▲ 13% |
| Employees (FTE) | 130.3 | 184.9 | 217.7 | 214.2 | ▼ 3.5 |
Key figures of DUOMED BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DUOMED BELGIUM?
What happened at DUOMED BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lana Gybels stepped down as director. NBB
- Diogo Santos De Lima stepped down as director. NBB
- Levico BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 10.4 million (▼ € 44.5 million vs 2024). Source: NBB ↗
- Lana Gybels became a director. NBB
- Diogo Santos De Lima became a director. NBB
- New establishment in Mechelen. KBO
- Levico BV became a director. NBB
In short
From € 1.7 million profit in 2022 to € 10.4 million loss in 2025.
Paid € 5.6 million in corporate taxes since 2022.
Best year ever: 2024, with € 34.1 million profit.
Pays suppliers within 85 days on average.
A new publication or filing at DUOMED BELGIUM? We notify you, reason included.
Follow DUOMED BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Duomed Holding Benelux comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DUOMED BELGIUMThe shares are held by Duomed Holding Benelux (100%). It owns 100% of EK Luxembourg, 100% of Duomed Holding France, 100% of Anandic Medical Systems AG, 100% of Duomed Holding Scandinavia, 100% of Launch Diagnostics Holding Ltd and 100% of Duomed South East Europe itself.
Directors
According to the 2025 annual accounts
Lana Gybels
Director
since 2025 · until 2031
Managing director · represented by Geert Kuys
Also active at: ORTHOSPINE, Duomed Holding Benelux, Palex Duomed Holding, GP DUOMA
since 2024 · until 2030
Diogo Santos De Lima
Director
since 2025 · until 2031
Shareholders
Participations
EK Luxembourg
100%
Duomed Holding France
100%
Anandic Medical Systems AG
100%
Duomed Holding Scandinavia
100%
Launch Diagnostics Holding Ltd
100%
Duomed South East Europe
100%
Duomed Holding Swiss AG
100%
Mar Medica DOO
100%
100%
Launch Diagnostics Deutschland GmbH
Duomed Scandinavia AS
Launch Diagnostics Ltd
Duomed Swiss AG
Launch Diagnostics France SaS
Vytil
Rey Medical AG
Systèmes Médicaux Diffusion SaS
Duomed France Solutions SAS
Establishments
Establishment units
Physical locations of this company
Vaartdijk 90
2800 Mechelen
Oeyvaersbosch 12
2630 Aartselaar
Active since 15 February 1977
Rue de l'Industrie 30c
1400 Nivelles
Active since 23 June 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →ORTHOSPINE same network
€ 46,117 revenue · 2025
AXI
€ 26.7 million revenue · 2025
AMISTA
€ 2.5 million gross margin · 2025
Duomed Holding Benelux same network
NESSI HOLDING
€ 391 gross margin · 2025
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0416.834.437
- VAT number
- BE 0416.834.437
- Registered office
- Vaartdijk 90, 2800 Mechelen
- Names & denominations
- DUOMED BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 February 1977
- Peppol
- Active · Active since 19 Sept 2024
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van holdings